BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30904736)

  • 1. Anti-Homer-3 antibody associated cerebellar ataxia: A rare case report and literature review.
    Xu X; Ren H; Li L; Wang J; Fechner K; Guan H
    J Neuroimmunol; 2019 May; 330():155-158. PubMed ID: 30904736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological Autoimmunity Associated With Homer-3 Antibody: A Case Series From China.
    Liu M; Ren H; Fan S; Zhang W; Xu Y; Zhao W; Guan H;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
    Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
    Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia.
    Zuliani L; Sabater L; Saiz A; Baiges JJ; Giometto B; Graus F
    Neurology; 2007 Jan; 68(3):239-40. PubMed ID: 17224583
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute Cerebellar Ataxia Associated with Modest Elevation of Anti-GAD Antibodies in a Young Patient.
    Gomez J; Jin D
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():620. PubMed ID: 30647991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Hot Cross Bun" Sign in a Patient with Glutamic Acid Decarboxylase 65-KDa Isoform Associated Cerebellar Ataxia: Case Report and Review of the Literature.
    Duan RN; He JZ; Cao LL
    Cerebellum; 2024 Jun; 23(3):1204-1210. PubMed ID: 37948023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report and literature analysis: Autoimmune cerebellar ataxia associated with homer-3 antibodies.
    Wu Q; Gong B; Jiang A; Qin X
    Front Neurol; 2022; 13():951659. PubMed ID: 35959384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
    Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
    Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review.
    Cai Y; Liu J; Ren H; Shi F; Che J; Geng Q; Tan Y; Guan H; Di W
    Neurol Sci; 2023 Jan; 44(1):397-403. PubMed ID: 36094774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
    Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
    J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
    Wallwitz U; Brock S; Schunck A; Wildemann B; Jarius S; Hoffmann F
    J Neuroimmunol; 2017 Aug; 309():77-81. PubMed ID: 28601293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient with homer-3 antibodies and cerebellitis.
    Höftberger R; Sabater L; Ortega A; Dalmau J; Graus F
    JAMA Neurol; 2013 Apr; 70(4):506-9. PubMed ID: 23400636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.
    di Biase L; Assenza G; Iorio R; Melgari JM; Salomone G; Marano M; Muda AO; Di Lazzaro V
    Parkinsonism Relat Disord; 2016 Sep; 30():78-80. PubMed ID: 27236207
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment.
    Rigamonti A; Lauria G; Stanzani L; Mantero V; Andreetta F; Salmaggi A
    J Neurol Sci; 2014 Jan; 336(1-2):169-70. PubMed ID: 24215945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody against the Rab6A/Rab6B in primary autoimmune cerebellar ataxia associated with Sjogren's syndrome: A case report.
    Guo L; Ren H; Fan S; Guan H; Wang J
    J Neuroimmunol; 2021 Oct; 359():577667. PubMed ID: 34332492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
    Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
    Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-MAG associated cerebellar ataxia and response to rituximab.
    Zis P; Rao DG; Hoggard N; Sarrigiannis PG; Hadjivassiliou M
    J Neurol; 2018 Jan; 265(1):115-118. PubMed ID: 29159464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of an anti-mouse cerebellar tissue-derived antigen antibody test in predicting immunotherapy efficacy in patients with idiopathic cerebellar ataxia].
    Ohtomo T; Ogino S; Yanai S; Nakayama S; Yajima R; Sugawara M; Yamada J; Aizawa H; Taguchi T; Nanri K
    Rinsho Shinkeigaku; 2022 Feb; 62(2):112-122. PubMed ID: 35095045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
    Yoshikura N; Kimura A; Fukata M; Fukata Y; Yokoi N; Harada N; Hayashi Y; Inuzuka T; Shimohata T
    J Neuroimmunol; 2018 Jun; 319():63-67. PubMed ID: 29685291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.